Stocklytics Platform
Asset logo for symbol IMMX
Immix Biopharma, Inc. Common Stock
IMMX65
$1.79arrow_drop_up5.95%$0.10
High Growth
Penny Stock
Asset logo for symbol IMMX
IMMX65

$1.79

arrow_drop_up5.95%

Performance History

Chart placeholder
Key Stats
Open$1.69
Prev. Close$1.68
EPS-0.84
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$49.23M
PE Ratio-
LOWHIGH
Day Range1.58
1.79
52 Week Range1.26
7.75
Ratios
Revenue-
EBITDA Margin %-
EPS-0.84

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Immix Biopharma, Inc. Common Stock (IMMX)

Immix Biopharma, Inc. Common Stock (IMMX) is a publicly traded company on the stock market. The company has a history of fluctuating stock prices, which can be seen in its price history. Investors can track the performance of IMMX stock over time to make informed decisions. The stock quote for IMMX provides the current market price for the company's shares. This information is important for investors who want to buy or sell IMMX stock. It is also important for tracking the stock's performance on a daily basis. Investors can stay up to date with the latest news about IMMX by reading the stock news. This news provides information about the company's recent developments, partnerships, and other important events. It helps investors understand the factors that may impact the stock's performance.
Analyzing IMMX stock is crucial for investors who want to make informed decisions. Stock analysis provides insights into the company's financials, performance, and future prospects. By analyzing the stock, investors can evaluate its potential for growth and make predictions about its future price movements. Smart analysis tools can assist investors in analyzing IMMX stock by providing advanced data analysis techniques. These tools use algorithms and machine learning to analyze large amounts of data. They can uncover patterns, trends, and correlations that may not be visible to the human eye. By using smart analysis, investors can gain a deeper understanding of IMMX stock and make more accurate predictions.
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Headquarters
Los Angeles
Employees
9
Exchange
NASDAQ
add Immix Biopharma, Inc. Common Stock to watchlist

Keep an eye on Immix Biopharma, Inc. Common Stock

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the market capitalization of Immix Biopharma, Inc. Common Stock (IMMX)?

Immix Biopharma, Inc. Common Stock (IMMX) has a market capitalization of $49.24M. The average daily trading volume is 1.68, indicating the stock's liquidity and investor engagement.
help

What is Immix Biopharma, Inc. Common Stock's (IMMX) price per share?

The current price per share for Immix Biopharma, Inc. Common Stock (IMMX) is $1.79. The stock has seen a price change of $0.1 recently, indicating a 5.95% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Immix Biopharma, Inc. Common Stock (IMMX)?

For Immix Biopharma, Inc. Common Stock (IMMX), the 52-week high is $7.75, which is 332.96% from the current price. The 52-week low is $1.26, the current price is 42.06% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Immix Biopharma, Inc. Common Stock (IMMX) a growth stock?

Immix Biopharma, Inc. Common Stock (IMMX) has shown an average price growth of -3.66% over the past three years. It has received a score of 92 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Immix Biopharma, Inc. Common Stock as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Immix Biopharma, Inc. Common Stock (IMMX) stock price performance year to date (YTD)?

As of the latest data, Immix Biopharma, Inc. Common Stock (IMMX) has a year-to-date price change of -70.46%. Over the past month, the stock has experienced a price change of 9.82%. Over the last three months, the change has been -16.74%. Over the past six months, the figure is -15.57%.
help

Is Immix Biopharma, Inc. Common Stock (IMMX) a profitable company?

Immix Biopharma, Inc. Common Stock (IMMX) has a net income of -$15.6M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 100%, providing insight into the company's sales performance and growth. Operating income is noted at -$16.14M. Furthermore, the EBITDA is -$20.18M.

News

Take Your Investments to a Whole New Level